Contact Us
Site Map
Search
Home
Nexavar for HCC
Nexavar for Advanced RCC
Nexavar Mechanism of Action
Professional Resources
Product Summary
Essential Information
Summary of Product Characteristics/ Prescribing Information
HCC Clinical Experience Presentations
RCC Clinical Experience Presentations
Bayer Links
Bayer Global
Bayer Schering Pharma
Bayer HealthCare
General Conditions of Use
Privacy Statement
Imprint
Copyright ©
Bayer HealthCare AG
Your browser does not support flash 8 or later which is needed to view this animation. Please visit
www.macromedia.com/go/getflashplayer
to download the flash player.
Site Map
Text Zoom
Nexavar for HCC
Overview of HCC
HCC Risk Factors
Pivotal Study: The SHARP Trial
Nexavar Efficacy in HCC
Nexavar Safety in HCC
Dosing Information
References
Nexavar for Advanced RCC
TARGET Phase III Clinical Trial Design and Results
Efficacy
Safety Profile
Dosing Information
Advanced RCC Nurse Guide and FAQ
References
Nexavar Mechanism of Action
The RAS/RAF/MEK/ERK Pathway and HCC
Uncontrolled Activation of the RAF/MAP/ERK Pathway
Rationale for Targeted Therapy in Advanced RCC
References
Professional Resources
Advanced RCC Nurse Guide and FAQ
Clinical Trials
Online Resources
Term
Explanation for term.
